Three times as many deaths in the study arm versus the control arm in a trial of ADC Therapeutics' Zynlonta have raised ...

With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its ...

The cutbacks are significant. Lilly will slice its planned investment of 2.3 billion euros ($2.7 billion) in half, while ...

Nearly a decade later, taking the center stage at ASCO 2026, Akeso’s ivonescimab made history by offering the first-ever ...

There were 487 exhibitor booths at the American Society of Clinical Oncology (ASCO)’s 2026 annual meeting, held in Chicago’s McCormick Place. Fierce Pharma Marketing attempted to see each one. Jazz's ...

More biopharma layoffs are hitting New Jersey, this time from Merck & Co.in the latest phase of headcount reductions ...

After submitting its timed-release version of a decades-old ADHD drug to the FDA nearly a year ago, Kansas City's Cingulate ...

Amid shifts in attitudes around family planning and contraception—and as the advent of telehealth outfits like Hims & Hers ...

Pharma solutions firm Cencora and Gilead Sciences have expanded their longstanding partnership, cutting a deal in which the distribution giant will support access to Gilead's CAR-T cancer therapies ...

It’s the moment of truth for Akeso’s ivonescimab, and to many, a high-stakes test for China’s booming biotech industry. | ...

The nonprofit, The Endometriosis Collective, has included Schumer and Monroe in the feature-length documentary “End of the ...

ViiV Healthcare is teaming up with TV personality, HIV and LGBTQ advocate Michelle Visage to help broaden awareness about new ...